232 related articles for article (PubMed ID: 2556828)
1. Orchiectomy only for clinical stage I nonseminomatous germ cell testis tumors: comparison with pathologic stage I disease.
Freiha F; Torti F
Urology; 1989 Dec; 34(6):347-8. PubMed ID: 2556828
[TBL] [Abstract][Full Text] [Related]
2. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
[TBL] [Abstract][Full Text] [Related]
3. Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease.
Socinski MA; Garnick MB; Stomper PC; Fung CY; Richie JP
J Urol; 1988 Dec; 140(6):1437-41. PubMed ID: 2848138
[TBL] [Abstract][Full Text] [Related]
4. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
Powles T
Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis.
Sogani PC
Urol Clin North Am; 1991 Aug; 18(3):561-73. PubMed ID: 1652171
[TBL] [Abstract][Full Text] [Related]
6. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
[TBL] [Abstract][Full Text] [Related]
7. Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
von Eschenbach AC; Swanson DA; Johnson DE; Wishnow KI; Stephenson RA; Babaian RJ
Prog Clin Biol Res; 1991; 370():385-92. PubMed ID: 1718009
[No Abstract] [Full Text] [Related]
8. Clinical stage I nonseminomatous germ cell tumors of testis. Observation vs retroperitoneal lymph node dissection.
Sujka SK; Huben RP
Urology; 1991 Jul; 38(1):29-31. PubMed ID: 1650970
[TBL] [Abstract][Full Text] [Related]
9. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation.
Donohue JP; Thornhill JA; Foster RS; Rowland RG; Bihrle R
J Urol; 1993 Feb; 149(2):237-43. PubMed ID: 8381190
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Pedraza AM; Stephenson AJ
Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.
Hamilton RJ; Nayan M; Anson-Cartwright L; Atenafu EG; Bedard PL; Hansen A; Chung P; Warde P; Sweet J; O'Malley M; Sturgeon J; Jewett MAS
J Clin Oncol; 2019 Aug; 37(22):1919-1926. PubMed ID: 30802156
[TBL] [Abstract][Full Text] [Related]
14. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
15. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
Lowe BA
Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with clinical stage I or II nonseminomatous germ cell tumors of the testis. Evolving therapeutic options.
Richie JP; Socinsky MA; Fung CY; Brodsky GL; Kalish LA; Garnick MB
Arch Surg; 1987 Dec; 122(12):1443-5. PubMed ID: 2446590
[TBL] [Abstract][Full Text] [Related]
17. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
18. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
20. Decision analysis defining optimal management of clinical stage 1 high-risk nonseminomatous germ cell testicular cancer with lymphovascular invasion.
Avulova S; Allen C; Morgans A; Moses KA
Urol Oncol; 2018 Jul; 36(7):342.e1-342.e6. PubMed ID: 29754945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
